Natalizumab para la enfermedad moderada a severamente activa de Crohn - horizonte opinión de exploración

Autores
Categoría Resumen estructurado de revisiones sistemáticas
RevistaHTA Database
Año 2004
Cargando información sobre las referencias

RECORD STATUS:

This is a bibliographic record of a published health technology assessment from a member of INAHTA. No evaluation of the quality of this assessment has been made for the HTA database.

CITATION:

NHSC. Natalizumab for moderate to severely active Crohn's disease - horizon scanning review Birmingham: National Horizon Scanning Centre (NHSC). 2004
Epistemonikos ID: 7e291dc2997ebc4362ef8fc585300234cec754ac
First added on: Feb 05, 2015